REFERENCE
EMEA.European Medicines Agency recommends withdrawal of the marketing authorisations for lumiracoxib-containing medicines. Media Release: 13 Dec 2007. Available from: URL: http://www.emea.europa.eu
Rights and permissions
About this article
Cite this article
Due to the risk of severe liver toxicity, the EMEA has recommended the withdrawal of all lumiracoxib-containing medicines. React. Wkly. 1183, 2 (2008). https://doi.org/10.2165/00128415-200811830-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200811830-00005